Assessment of Self-Medication Pattern During Outbreak of Coronavirus Disease in Himachal Pradesh, a Northwestern Himalayan Region of India
Home >
2025,
Vol. 13 No. 01 > Assessment of Self-Medication Pattern During Outbreak of Coronavirus Disease in Himachal Pradesh, a Northwestern Himalayan Region of India
Published: September 30, 2025
Authors
Raveen Chauhan, Swati Pundir, Naresh Vashist, Chirag Dhawan, Arun Parashar, and Ranjan Kumar
Keywords
Self-medication, Coronavirus Disease, Himachal Pradesh, Over-the-counter drugs, Public health policy, Primary care
Abstract
Background: Self-medication (SM) is a major global health issue, especially in low- and middle-income countries with limited healthcare access. During Coronavirus disease, fear, misinformation, and restricted services worsened the problem. This study examined SM prevalence, patterns, and determinants in Himachal Pradesh, India.
Purpose: This research aimed to determine the prevalence, pattern, and awareness of self-medication (SM) during the Coronavirus disease outbreak in the general public when no preventive or curative therapy was available.
Methods: A descriptive cross-sectional, web-based survey was carried out from January to May 2021 using a pre-validated questionnaire distributed via social media platforms. Owing to pandemic-related constraints, convenience sampling was employed. Eligible participants were residents of Himachal Pradesh aged ≥18 years who provided informed consent. Respondents with incomplete submissions or reporting multiple drug use for unrelated conditions were excluded. Of 654 initial responses, 527 met the criteria for analysis. Descriptive statistics summarized demographic and clinical data, and chi-square tests assessed associations between categorical variables.
Results: Among the 527 respondents, 48.5% were male and 51.5% female; nearly half (48.5%) were aged 25–35 years. Fever (30.4%) was the most frequently reported reason for SM, followed by sore throat (19.4%) and weakness (16.7%). Commonly self-administered medicines included paracetamol (33.6%), azithromycin (21.8%), and doxycycline (14.6%). Only 24% reported obtaining medicines on a physician’s advice, while pharmacies and personal networks were predominant information sources. Chi-square analysis revealed a statistically significant association between education level and drug choice (p < 0.05). Notably, 85% of participants were unaware of the risks of overdose or adverse effects.
Conclusion: The study concludes that 24% of respondents took medication on a physician’s advice, while the remaining 76% sought SM. Inappropriate self-medication might result in irrational treatment and serious health issues. Therefore, there is an urgent need to monitor and manage SM-related practices. SM was widely practiced in Himachal Pradesh during the Coronavirus disease pandemic, driven by limited healthcare availability and misinformation. Targeted public health education, stricter regulation of over-the-counter drug sales, and community-level awareness initiatives are essential to address this issue.
References
- Amuzie, C. I., Kalu, K. U., Izuka, M., Nwamoh, U. N., Emma-Ukaegbu, U., Odini, F., Metu, K., Ozurumba, C., & Okedo-Alex, I. N. (2022). Prevalence, pattern and predictors of self-medication for COVID-19 among residents in Umuahia, Abia State, Southeast Nigeria: Policy and public health implications. Journal of Pharmaceutical Policy and Practice, 15(1), 1–9. https://doi.org/10.1186/s40545-022-00451-w
- Ayosanmi, O. S., Alli, B. Y., Akingbule, O. A., Alaga, A. H., Perepelkin, J., Marjorie, D., Sansgiry, S. S., & Taylor, J. (2022). Prevalence and correlates of self-medication practices for prevention and treatment of COVID-19: A systematic review. Antibiotics, 11(6), 808. https://doi.org/10.3390/antibiotics11060808
- Chouhan, K. I., & Prasad, S. B. (2016). Self-medication and their consequences: A challenge to health professional. Asian Journal of Pharmaceutical and Clinical Research, 9(2), 314–317. https://journals.innovareacademics.in/index.php/ajpcr/article/view/10675
- Dhadwal, S., & Bhutani, S. (2017). Availability of health services in Himachal Pradesh. International Journal of Advanced Research and Development, 2(6), 231–238.
- Erku, D. A., Belachew, S. A., Abrha, S., Sinnollareddy, M., Thomas, J., Steadman, K. J., & Tesfaye, W. H. (2021). When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the ‘infodemic’ surrounding COVID-19. Research in Social and Administrative Pharmacy, 17(1), 1954–1963. https://doi.org/10.1016/j.sapharm.2020.04.032
- Farah, R., Kazzi, Z., Brent, J., Burkhart, K., Wax, P., Aldy, K., & Toxicology Investigators Consortium FACT Study Group. (2022). Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project. Clinical Toxicology, 60(8), 942–946. https://doi.org/10.1080/15563650.2022.2051569
- Hache, G., Rolain, J. M., Gautret, P., Deharo, J. C., Brouqui, P., Raoult, D., & Honoré, S. (2021). Combination of hydroxychloroquine plus azithromycin as potential treatment for COVID-19 patients: Safety profile, drug interactions, and management of toxicity. Microbial Drug Resistance, 27(3), 281–290. https://doi.org/10.1089/mdr.2020.0349
- Johnson, R. M., & Vinetz, J. M. (2020). Dexamethasone in the management of COVID-19. BMJ, 370, m2648. https://doi.org/10.1136/bmj.m2648
- Malik, M., Tahir, M. J., Jabbar, R., Ahmed, A., & Hussain, R. (2020). Self-medication during COVID-19 pandemic: Challenges and opportunities. Drugs & Therapy Perspectives, 36, 565–567. https://doi.org/10.1007/s40267-020-00785-z
- Mallhi, T. H., Khan, Y. H., Alotaibi, N. H., Alzarea, A. I., Alanazi, A. S., Qasim, S., Iqbal, M. S., & Tanveer, N. (2021). Drug repurposing for COVID-19: A potential threat of self-medication and controlling measures. Postgraduate Medical Journal, 97(1153), 742–743. https://doi.org/10.1136/postgradmedj-2020-138447
- Marathe, P. A., Kamat, S. K., Tripathi, R. K., Raut, S. B., & Khatri, N. P. (2020). Over-the-counter medicines: Global perspective and Indian scenario. Journal of Postgraduate Medicine, 66(1), 28–34. https://doi.org/10.4103/jpgm.JPGM_163_19
- Nasir, M., Mannan, M., Salauddin Chowdhury, A. S. M., Zahan, T., & Perveen, R. A. (n.d.). Prevalence, pattern and impact of self-medication of anti-infective agents during COVID-19 outbreak in Dhaka City.
- Onchonga, D. (2020). A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharmaceutical Journal, 28(7), 903–904. https://doi.org/10.1016/j.jsps.2020.06.007
- Quispe-Cañari, J. F., Fidel-Rosales, E., Manrique, D., Mascaró-Zan, J., Huamán-Castillón, K. M., Chamorro–Espinoza, S. E., Garayar–Peceros, H., Ponce–López, V. L., Sifuentes-Rosales, J., Alvarez-Risco, A., & Yáñez, J. A. (2021). Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. Saudi Pharmaceutical Journal, 29(1), 1–11. https://doi.org/10.1016/j.jsps.2020.12.001
- World Health Organization. (2000). Guidelines for the regulatory assessment of medicinal products for use in self-medication. https://apps.who.int/iris/bitstream/handle/10665/66154/WHO_EDM_QSM_00.1_eng.pdf
- World Health Organization. (2020). Coronavirus disease (COVID-19) advice for the public: MythBusters. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/mythbusters
- Yasmin, F., Asghar, M. S., Naeem, U., Najeeb, H., Nauman, H., Ahsan, M. N., & Khattak, A. K. (2022). Self-medication practices in medical students during the COVID-19 pandemic: A cross-sectional analysis. Frontiers in Public Health, 10, 803937. https://doi.org/10.3389/fpubh.2022.803937
- Yousef, A. M., Al-Bakri, A. G., Bustanji, Y., & Wazaify, M. (2008). Self-medication patterns in Amman, Jordan. Pharmacy World & Science, 30(1), 24–30. https://doi.org/10.1007/s11096-007-9135-x
How to Cite
Raveen Chauhan, Swati Pundir, Naresh Vashist, Chirag Dhawan, Arun Parashar, and Ranjan Kumar . Assessment of Self-Medication Pattern During Outbreak of Coronavirus Disease in Himachal Pradesh, a Northwestern Himalayan Region of India.
J. Pharm. Technol. Res. Manag.. 2025, 01, 29-35